6-Bromo-1-methyl-1,2,3,4-tetrahydroquinoxaline, 95.0%, 250mg

METHYL-(4-PHENYL-BUTYL)-AMINE HCL, 95.0%, 5g

5-Benzyl-4-phenyl-4H-1,2,4-triazole-3-thiol, 5g

7-Chloro-[1,2,4]triazolo[1,5-a]pyridine, 97%, 1g

2-Chloro-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide, 95.0%, 10g

ARCA Cap Analog, ≥98%, 10 µl, plastic package.

(S)-2-((4-methoxyphenyl)sulfonamido)-2-phenylacetic acid, 98%, 250mg

1,1'-(5'-(4-(1H-Imidazol-1-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(1H-imidazole), 97%, 10g

(2E)-3-methyl-3-(methylamino)butan-2-one oxime, 95.0%, 1g

3-Bromo-4-chloro-5-fluoropyridine, 95.0%, 250mg

5-Iodo-2'-deoxyuridine>99.0%(T)5g

5-Ethynyl-1H-1,2,3-triazole, 95%, 100mg

2-{4-[(TERT-BUTYL)OXYCARBONYL]PIPERAZINYL}-2-(2-THIENYL)ACETIC ACID, 95.0%, 250mg